Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The entry "Elongation factor for RNA polymerase II 2 pseudogene 1 (ELL2P1)" refers to a pseudogene and does not encode a functional protein or receptor. Its name suggests it is related to the functional gene ELL2, which encodes a general transcription elongation factor involved in increasing the rate of RNA polymerase II transcription by suppressing pausing on DNA templates[2][1]. The functional ELL2 protein acts directly on the ternary elongation complex and is classified as a transcription elongation factor, but ELL2P1 itself plays no direct biological or therapeutic role, has no molecular function, drug interactions, or disease implications known in the literature. If a functional elongation factor is the intended target, information should pertain to ELL2 (Elongation factor for RNA polymerase II 2) instead. In summary, the name ELL2P1 describes a pseudogene and not a functional target or receptor. Any structured information should be mapped to the functional gene ELL2 in cases where a transcription elongation factor is desired, not the pseudogene ELL2P1.
None (not functional)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Elongation factor for RNA polymerase II 2 pseudogene 1 (ELL2P1).